Enanta Pharmaceuticals In... (ENTA)
undefined
undefined%
At close: undefined
6.06
0.00%
After-hours Dec 13, 2024, 07:23 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Net Income -116.05M -133.82M -121.75M -79.00M -36.17M 46.38M 71.96M 17.71M 21.67M 78.99M 34.44M 9.63M 21.40M 23.31M 7.90M
Depreciation & Amortization 2.34M 2.37M 2.97M 3.33M 3.64M 3.26M 2.52M 2.14M 1.66M 639.00K 352.00K 221.00K 172.00K 499.00K 553.00K
Stock-Based Compensation 26.80M 28.22M 26.97M 20.99M 19.57M 19.23M 15.85M 13.07M 9.35M 5.84M 2.68M 1.06M 424.00K 225.00K 259.00K
Other Working Capital 6.57M -243.00K 8.16M -17.38M 2.26M 291.00K -92.00K 478.00K 397.00K 649.00K -10.00K 15.00K 22.00K -814.00K -20.14M
Other Non-Cash Items 1.02M 2.60M 242.00K -1.98M -3.47M -5.80M -1.17M -581.00K -749.00K -2.99M 176.00K -1.78M 535.00K 2.75M -480.00K
Deferred Income Tax - -10.55M - 345.00K 10.61M -3.14M 1.86M -1.65M -2.29M 11.03M -15.21M 781.00K - -360.00K -
Change in Working Capital 7.13M 8.02M 6.79M -13.69M 12.90M 11.49M -61.79M 21.97M 6.17M -16.83M -2.26M 741.00K 93.00K -2.40M -18.41M
Operating Cash Flow -78.76M -103.15M -84.78M -70.00M 7.09M 71.42M 29.22M 52.65M 35.81M 76.67M 20.18M 10.65M 22.62M 24.02M -10.18M
Capital Expenditures -17.95M -9.06M -2.13M -750.00K -1.45M -5.42M -2.98M -2.51M -4.74M -2.34M -1.03M -606.00K -252.00K -445.00K -37.00K
Acquisitions - 44.52M -54.90M -37.74M -21.27M 86.66M - - - 9.00K - - 66.00K 9.00K -
Purchase of Investments -307.28M -373.39M -171.45M -307.35M -338.55M -549.31M -293.10M -251.37M -192.43M -196.30M -98.41M -115.89M -47.69M -33.57M -603.00K
Sales Maturities Of Investments 383.46M 328.87M 228.47M 345.09M 359.83M 468.06M 260.68M 249.31M 153.50M 110.62M 99.93M 47.28M 28.70M 16.76M 2.30M
Other Investing Acitivies - -44.52M 54.90M 37.74M 21.27M -86.66M -32.42M -2.07M -38.92M -172.00K 3.00K -68.61M 1.14M -436.00K -
Investing Cash Flow 58.23M -53.58M 54.90M 36.99M 19.83M -86.66M -35.40M -4.57M -43.66M -88.19M 497.00K -69.22M -18.04M -17.68M 1.66M
Debt Repayment -27.48M - - - - -86.00K -79.00K -73.00K -68.00K - - - - - -7.00K
Common Stock Repurchased - - -1.23M -534.00K -1.50M -4.19M -1.76M -202.00K - - - - - - -
Dividend Paid - - - - - - - - - - - - - - -
Other Financial Acitivies -147.00K 198.13M 20.03M 3.08M 8.98M 2.66M 4.49M 1.09M 2.77M 2.54M 1.16M -2.98M -909.00K 34.00K 15.00K
Financial Cash Flow -27.63M 198.13M 20.03M 3.08M 8.98M 2.57M 4.41M 1.02M 2.71M 2.54M 1.16M 56.91M -909.00K 34.00K 8.00K
Net Cash Flow -48.16M 41.39M -9.85M -29.93M 35.90M -12.67M -1.77M 49.10M -5.15M -8.97M 21.84M -1.65M 3.67M 6.37M -8.50M
Free Cash Flow -96.71M -112.21M -86.91M -70.75M 5.64M 66.00M 26.24M 50.15M 31.07M 74.34M 19.15M 10.05M 22.37M 23.57M -10.21M